NCT05879991View on ClinicalTrials.gov

A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 10, 2023

Primary Completion Date

October 19, 2023

Study Completion Date

October 19, 2023

Conditions
Healthy
Interventions
DRUG

zongertinib (C-14)

Oral solution

DRUG

zongertinib

Film-coated tablet

DRUG

zongertinib (C-14)

Solution for infusion

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05879991 - A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body | Biotech Hunter | Biotech Hunter